Home > News > Biophage Pharma appoints Dr. Pearl Chin to Board of Directors
October 4th, 2005
Biophage Pharma appoints Dr. Pearl Chin to Board of Directors
Biophage Pharma is pleased to announce the appointment of Dr. Pearl Chin to its Board of Directors. Dr.
Chin is the founder and managing Director of Seraphima Ventures, a private equity fund focused on Nanotechnology.
Dressing a metal in various colors: DGIST research developed a technology to coat metal with several nanometers of semiconducting materials January 17th, 2017
Nanoparticle exposure can awaken dormant viruses in the lungs January 17th, 2017
Nanoscale view of energy storage January 16th, 2017
Seeing the quantum future... literally: What if big data could help you see the future and prevent your mobile phone from breaking before it happened? January 16th, 2017
Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016
Dr Barbara Armbruster joins XEI Scientific as Marketing Director June 1st, 2016
Park Systems Global Expansion in AFM Market Includes Appointment of New Executives April 23rd, 2016
GLOBALFOUNDRIES Adds Alain Mutricy as Head of Product Management Group March 3rd, 2016